Dendritic Aptamer-Drug Conjugates for High Loading and Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current aptamer-drug conjugates (ApDC) face challenges in achieving high drug-loading ratios due to complex synthesis and poor water solubility, leading to low conjugation efficiency and difficulty in precisely controlling the drug-loading ratio, which affects their clinical efficacy.
Innovation Solution
The use of a dendritic structure linker and solid-phase synthesis with click chemistry reactions enables the design and efficient synthesis of high drug-loading ratio ApDC, enhancing conjugation efficiency and water solubility, allowing for precise control of drug-loading ratios.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If high drug-loading ratio drug precursors are used to increase drug-loading ratio, then the drug-loading ratio is improved, but the synthesis complexity increases and water solubility deteriorates
Solution Approach 1:
The drug precursor is divided into modular components that can be independently synthesized and then assembled. The dendritic structure is built through stepwise addition of drug molecules to a central core, allowing each component to be optimized separately while maintaining overall high drug-loading ratio.
Solution Approach 2:
A dendritic linker structure serves as an intermediary between the aptamer and multiple drug molecules. This linker contains multiple reactive groups that facilitate controlled conjugation of drug precursors to the aptamer, simplifying the overall synthesis process while achieving high drug-loading ratios.
2Quantity of substance
If high drug-loading ratio drug precursors are used to increase drug-loading ratio, then the drug-loading ratio is improved, but the water solubility deteriorates
Solution Approach 1:
The dendritic linker structure incorporates hydrophilic groups (such as hydroxyl or carboxyl groups) at its periphery while maintaining hydrophobic drug cores. This creates local regions of different polarity, where the hydrophilic regions interact with water to maintain solubility while the hydrophobic drug regions provide high drug-loading capacity.
Solution Approach 2:
The drug precursor combines hydrophobic drug molecules with a hydrophilic dendritic framework to create a composite structure. This composite maintains water solubility through the hydrophilic dendritic regions while achieving high drug-loading ratios through the dense packing of multiple drug molecules on the dendritic structure.
3Ease of manufacture
If traditional conjugation methods are used, then the synthesis process is simple, but the conjugation efficiency deteriorates and precise control of drug-loading ratio becomes difficult
Solution Approach 1:
The dendritic linker is pre-synthesized with a specific number of reactive groups before conjugation to the aptamer. This preliminary preparation ensures that the exact desired drug-loading ratio is built into the structure, allowing precise control without requiring complex stepwise conjugation procedures during the main synthesis.
4Ease of manufacture
If traditional conjugation methods are used, then the synthesis process is simple, but the conjugation efficiency deteriorates
Solution Approach 1:
The invention changes the chemical parameters of the conjugation reaction by using dendritic linkers with multiple identical reactive groups that react with complementary groups on the aptamer and drug molecules. This standardized chemical interface dramatically improves conjugation efficiency and reliability while maintaining relative simplicity in the overall synthesis protocol.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The high drug-loading ratio ApDC demonstrates excellent antitumor activity against malignant tumors, with inhibition efficiencies exceeding 90% and significantly reduced IC50 values compared to single-loaded ApDC, particularly effective in treating colorectal, breast, and ovarian cancers.
Implementation Method 1
By using phosphodiester bonds as the backbone of the linker, the water solubility of the drug is improved, thereby increasing the drug conjugation efficiency.
Implementation Method 2
By using a linker with a dendritic structure and integrating solid-phase synthesis with efficient click chemistry reactions, the invention enables the design and efficient synthesis of high drug-loading ratio ApDC.
Implementation Method 3
By using phosphodiester bonds as the backbone of the linker, the water solubility of the drug is improved, thereby increasing the drug conjugation efficiency.
Data Source
AI summary
The invention provides a high drug-loading ratio aptamer-drug conjugates (ApDC) and its applications. By using a linker with a dendritic structure and combining solid-phase synthesis with efficient click chemistry reactions, the invention enables the design and efficient synthesis of high drug-loading ratio ApDC. These drugs demonstrate excellent tumor-inhibiting activity in antitumor applications. Moreover, different drug-loading ratios can be designed to achieve higher efficacy for different drugs, resulting in ApDC with enhanced therapeutic effects. The invention exhibits outstanding antitumor effects against malignant tumors such as lung cancer, colorectal cancer, breast cancer, and ovarian cancer, with an inhibition efficiency exceeding 90%.